Breast cancer
Invited discussant abstracts 56PD, 57PD and 58PD
Date
20 Dec 2015Session
Breast cancerPresenters
Masakazu ToiAuthors
M. ToiAuthor affiliations
- Department Of Breast Surgery, Kyoto University Hospital, 606-8507 - Kyoto/JP
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
View the abstracts discussed:
- Quality of life in TSU-68 study: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline
- Multicenter observational study of fulvestrant 500 mg in postmenopausal Japanese women with ER positive advanced or recurrent breast cancer after prior endocrine treatment (SBCCSG29 study)
- Comparison of efficacy of neoadjuvant chemotherapy FEC 100 and docetaxel 75 versus AC and docetaxel in locally advanced breast cancer - a randomized clinical study
Resources from the same session
1132 - Efficacy and safety of palbociclib plus fulvestrant in Asian women with hormone receptor-positive (HR+)/human epidermal growth factor-2 negative (HER2-) metastatic breast cancer (MBC) that progressed on prior endocrine therapy (ET)
Presenter: Jungsil Ro
Session: Breast cancer
Resources:
Abstract
Slides
Webcast
438 - Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival by body weight and anti-drug antibody status
Presenter: Jin-Seok Ahn
Session: Breast cancer
Resources:
Abstract
Invited discussant abstracts 53O and 55O
Presenter: Rebecca Dent
Session: Breast cancer
Resources:
Slides
Webcast
Breast cancer epidemiology in Asia
Presenter: Masakazu Toi
Session: Breast cancer
Resources:
Slides
Webcast
Changes in tumour expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in Japanese breast cancer registry
Presenter: Naoki Niikura
Session: Breast cancer
Resources:
Slides
Webcast
853 - Quality of life in TSU-68 study: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline
Presenter: Byeong Seok Sohn
Session: Breast cancer
Resources:
Abstract
541 - Multicenter observational study of fulvestrant 500 mg in postmenopausal Japanese women with ER positive advanced or recurrent breast cancer after prior endocrine treatment (SBCCSG29 study)
Presenter: Kei Kimizuka
Session: Breast cancer
Resources:
Abstract
1271 - Comparison of efficacy of neoadjuvant chemotherapy FEC 100 and docetaxel 75 versus AC and docetaxel in locally advanced breast cancer - a randomized clinical study
Presenter: K M Dhanraj
Session: Breast cancer
Resources:
Abstract
453 - Comparison of incidental radiation dose to axilla and internal mammary nodal area by conventional, 3DCRT, and IMRT technique in carcinoma of breast
Presenter: H B Govardhan
Session: Breast cancer
Resources:
Abstract
530 - Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Presenter: Changhoon Yoo
Session: Breast cancer
Resources:
Abstract
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.